Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effectiveness of a Physical Activity Program (EPAP)

17. juni 2026 oppdatert av: Federal University of Pará

Effectiveness of a Physical Activity Program in Adults and the Elderly

study with multicomponent exercise

Studieoversikt

Detaljert beskrivelse

The objective of this research is to evaluate the effectiveness of a multicomponent physical activity program on the physical fitness of adults and the elderly. Participants will be adults and elderly individuals who perform physical activities in an extension project at the Federal University of Pará, Castanhal Campus, three times a week for 60 minutes. Each class will emphasize two physical capacities. Physical assessments will take place at the beginning and end of the school year and will include evaluations of the participants' profile, anthropometry, physical capacities, blood pressure, handgrip strength, and mental health. This research project aims to achieve the following goals: Conduct at least 80 assessments each year; Improve quality of life; Improve physical capacities; Reduce body circumferences; Improve muscle strength and handgrip strength; Encourage the participation of Physical Education students in research projects; Guide students in scientific work and in the preparation of their Final Course Projects; Participate in scientific events with presentations of work resulting from this research. Keywords: Adults; elderly people; physical activity; physical abilities.

Studietype

Intervensjonell

Registrering (Faktiske)

20

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Pará
      • Castanhal, Pará, Brasil, 68746-630
        • Universidade Federal do Pará

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Adults
  • Older adults
  • Over 50 years of age of both sexes
  • Participating in an extension program at Federal University of Pará
  • Self-reported diagnosis of hypertension.

Exclusion Criteria:

  • Participants who did not agree with the study
  • Participants Who have low attendance in classes (below 50%).

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Intervention Group (IG)

The IG followed this protocol:

Week 1 - Day 1: thirty minutes of aerobic resistance exercises and 30 minutes of balance exercises; Day 2: 30 minutes of balance exercises.

Week 2 - Day 1: thirty minutes of strength exercises for upper and lower limbs and 30 minutes of balance exercises; Day 2: 30 minutes of balance exercises.

After week 2, the training returned to week 1 until completing ten weeks. The balance exercises used in the classes were static and dynamic, with 6 to 7 exercises and a duration of 30 to 45 minutes. In the first three weeks, the balance exercises were performed with two sets of 12 to 15 repetitions. From the fourth week onwards, there was a progression to three sets of 12 repetitions, and in the last four weeks, the exercises were performed with four sets of 12 repetitions.

Participants who were randomized to the intervention group performed 10 weeks of body balance exercise.
Participants who were randomized to the intervention or control group performed 10 weeks of multicomponent exercise.
Aktiv komparator: Control

Week 1 - Days 1 and 2: 30 minutes of aerobic endurance exercises and 30 minutes of flexibility exercises.

Week 2: Days 1 and 2: 30 minutes of strength training for upper and lower limbs and 30 minutes of balance exercises.

After week 2, the training returned to week 1 until completing the ten weeks.

Participants who were randomized to the intervention or control group performed 10 weeks of multicomponent exercise.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in lower limb muscle strength
Tidsramme: Baseline and after 10 weeks
The assessments included tests of lower limb strength (sit-to-stand test) - In this test, the participant must sit down and stand up from a chair. The total number of repetitions in 30 seconds is recorded.
Baseline and after 10 weeks
Change in upper limb strength
Tidsramme: Baseline and 10 weeks
Upper limb strength (forearm flexion test) - The forearm flexion test assesses upper body strength using two-kilogram dumbbells for women and four-kilogram dumbbells for men, a chair with a backrest (without armrests), and a stopwatch. The participant must be seated against the chair with an upright posture, performing the greatest number of bicep curls with their dominant hand in thirty seconds.
Baseline and 10 weeks
Change in lower limb flexibility
Tidsramme: Baseline and 10 weeks
Lower limb flexibility (sit-and-reach test) - With the leg extended (but not overextended), the participant slowly leans forward, keeping the spine as straight as possible and the head aligned with the spine. The participant attempts to touch their toes by sliding their hands, one on top of the other, with the tips of their middle fingers, down the extended leg. The evaluator uses a 45 cm ruler and records the distance (cm) to the toes (minimum result) or the distance (cm) that can be reached beyond the toes (maximum result).
Baseline and 10 weeks
Change in body balance
Tidsramme: Baseline and 10 weeks
agility/dynamic balance (sit-to-walk 2.44m and return to sit test) - The person being evaluated starts in a seated position in a chair with an upright posture, hands on thighs and feet on the floor with one foot slightly in front of the other. At the signal, the person being evaluated gets up from the chair (they can push off with their thighs or the chair), walks as quickly as possible around the cone, returns to the chair and sits down. For reliable timing, the evaluator should start the stopwatch at the signal movement, whether or not the person has started moving, and stop the stopwatch the exact moment the person sits down in the chair.
Baseline and 10 weeks
Change in upper limb flexibility
Tidsramme: Baseline and 10 weeks
Upper limb flexibility (behind-the-back reach test) - Standing, the subject places their preferred hand on the same shoulder, palm open and fingers extended, reaching as far as possible to the middle of their back (elbow pointing upwards). The hand of the other arm is placed behind the back, palm upwards, reaching upwards as far as possible in an attempt to touch or overlap the extended middle fingers of both hands. Without moving the subject's hands, the evaluator helps to verify if the middle fingers of each hand are pointing towards each other. The overlap distance, or the distance between the tips of the middle fingers, is measured to the nearest centimeter. Negative results (-) represent the shortest distance between the middle fingers; positive results (+) represent the overlap of the middle fingers.
Baseline and 10 weeks
Change in aerobic endurance
Tidsramme: Baseline and 10 weeks
Aerobic endurance (6-minute walk) - At the indicated signal, participants walk as fast as possible (without running) around the course as many times as they can within the time limit. During the test, participants may stop and rest if necessary, and then resume walking. The evaluator must move onto the course after all participants have started and must record the elapsed time. The 6-minute walk test uses a 45.7 m course measured in 4.57 m segments. The distance covered in the 6-minute interval will be assessed.
Baseline and 10 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in body mass
Tidsramme: Baseline and 10 weeks
Body mass (BM) - measurement obtained in kilograms using a digital scale.
Baseline and 10 weeks
Height Assessment
Tidsramme: Baseline and 10 weeks
Height (meters) - will be obtained using a stadiometer.
Baseline and 10 weeks
Change in waist circumference
Tidsramme: Baseline and 10 weeks
waist circumference (WC) - measurement obtained in centimeters using a measuring tape
Baseline and 10 weeks
Change in hip circumference
Tidsramme: Baseline and 10 weeks
Hip circumference (HC) - a measurement obtained in centimeters using a measuring tape.
Baseline and 10 weeks
Change in Body Mass Index (BMI)
Tidsramme: Baseline and 10 weeks
Body Mass Index (BMI) - will be assessed by dividing body mass in kilograms by height squared in meters.
Baseline and 10 weeks
Change in Percentage of fat
Tidsramme: Baseline and 10 weeks
Percentage of fat (%BF) - a measurement obtained as a percentage using a bioimpedance scale.
Baseline and 10 weeks
Change in percentage of skeletal muscle
Tidsramme: Baseline and 10 weeks
Percentage of skeletal muscle (%SM) - a measurement obtained as a percentage using a bioimpedance scale.
Baseline and 10 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

25. august 2025

Primær fullføring (Faktiske)

18. september 2025

Studiet fullført (Faktiske)

2. desember 2025

Datoer for studieregistrering

Først innsendt

29. mai 2026

Først innsendt som oppfylte QC-kriteriene

17. juni 2026

Først lagt ut (Faktiske)

23. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

23. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • EPAP

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere